SEC 01 design + dev REV 2023

Calidi Biotherapeutics

SEC 02 Overview

Website for a clinical-stage biotech company developing targeted immunotherapies for cancer. Needed to balance scientific credibility with accessibility for investors.

SEC 03 The Work

Designed and built the full site. Clean, authoritative visual language with generous whitespace and clear information hierarchy. Pipeline pages, investor content, team bios — all responsive and fast.

SEC 04 Tech
[ Webflow ][ Custom Design ][ UI/UX ][ CMS ]